Purchase Order HT001425P0095
Award Date
5/15/25
Potential Completion Date
5/27/25
Potential Value
$212K
Federal Agency
Defense Health Agency
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Defense's Defense Health Agency (DHA) awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call order to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The $157,041.40 contract is for the delivery of four (4) treatment radiopharmaceutical LUTATHERA, a targeted radioligand therapy used for cancer treatment and diagnostic imaging. This order is part of a larger $26 million...
This is a federal contract award to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract, valued at $84,993.58, is a delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with the Department of Veterans Affairs (VA). The contract is for the supply of LUTATHERA, a radiopharmaceutical product used in cancer treatment and diagnostic imaging. The contract has no...
This federal contract award was made by the Veterans Integrated Service Network 17 (VISN 17) of the Department of Veterans Affairs (VA) to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract is for the radiopharmaceutical drug LUTATHERA (lutetium Lu 177 dotatate) and has a ceiling value of $925,206.54. It is a delivery order contract issued under the Pharmaceuticals and Drugs Federal Supply...
This is a federal contract award to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract, valued at $2,919,798.46, is a delivery order issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Veterans Integrated Service Network 21, a civilian agency within the Department of Veterans Affairs (VA). The contract is for the supply of LU-177 LUTATHERA DOTATATE, a...
This federal contract award was issued by the Veterans Integrated Service Network 4 (VISN 4), a division of the U.S. Department of Veterans Affairs (VA), to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The $1,934,973.04 Firm Fixed Price delivery order contract will deliver LUTATHERA and PLUVICTO isotopes, which are used in cancer treatment and diagnostic imaging procedures, through December 31, 2025....
This is a firm fixed-price delivery order award to Advanced Accelerator Applications USA Inc., a foreign-owned manufacturer of radiopharmaceuticals. The $201,454.79 contract is for the supply of LUTATHERA, a lutetium Lu 177 dotatate product used for cancer treatment. The award falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not have a set-aside designation. Advanced Accelerator Applications USA Inc. is an experienced provider of nuclear medicine solutions...
This is a firm fixed price BPA call order awarded by the Defense Health Agency to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals. The contract, valued at $221,750.00, is for the delivery of six branded nuclear medicine FDA-approved Lutathera products. The contract has a completion date of January 30, 2023 and does not utilize a set-aside. Advanced Accelerator Applications USA Inc. is a radiopharmaceutical company that provides...
The Department of Veterans Affairs Veterans Health Administration has awarded a firm fixed price delivery order to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer of radiopharmaceuticals, to provide 3 doses of Lutetium Dotatate. The $112,221.42 contract was awarded on June 3, 2021, with a completion date of December 31, 2021. This order was placed through the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. Advanced Accelerator Applications USA...
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of goods. The order is for 12 doses of the radiopharmaceutical product LU 177 DOTATE (LUTATHERA) with a potential value of $483,315.02. The order was placed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract vehicle. The contract has no set-aside designation...
This federal contract award to Advanced Accelerator Applications USA Inc. is for the initial four patient doses of the Lutathera radiopharmaceutical treatment for neuroendocrine cancer. The $144,400.00 firm fixed price purchase order was issued by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 23 and has a completion date of September 30, 2018. Advanced Accelerator Applications USA Inc. is a radiopharmaceutical company that...